Christopher T Rentsch

Christopher T Rentsch is an Assistant Professor in the Department of Internal Medicine at Yale School of Medicine and holds an adjunct position at the London School of Hygiene & Tropical Medicine. His research focuses on leveraging electronic health records (EHRs) to evaluate drug safety and efficacy, particularly in HIV/AIDS, liver disease, and public health crises like the COVID-19 pandemic. He co-leads the Veterans Aging Cohort Study (VACS) Pharmacoepidemiology Core and directs pharmacoepidemiology training programs at LSHTM.

Education:

• PhD, London School of Hygiene & Tropical Medicine (2018)
• PGDip, London School of Hygiene & Tropical Medicine (2017)
• MPH, Emory University (2011)
• BA, The Ohio State University (2008)

Research Interests: Dr. Rentsch specializes in real-world evidence generation, with emphasis on causal inference methodologies, health equity, and the application of EHR data to address critical public health questions. His work spans HIV/HCV comorbidity, polypharmacy, and drug safety in vulnerable populations. He has co-edited a seminal open-access textbook on COVID-19 Real-World Evidence Primer to standardize methodological approaches in pandemic research.

Awards & Leadership:

• 2024: Elected Fellow of the International Society of Pharmacoepidemiology (ISPE)
• 2024: ISPE Board of Directors Member
• 2022: ISPE Special Award for Pandemic Contributions
• 2021: ISPE Emerging Leader Award

Labs & Teams: Leads the VACS Pharmacoepidemiology Core and the EHR Research Group at LSHTM. Active in global initiatives like the OpenSAFELY platform for pandemic modeling.